Education
About Us
Working with TipRanks
Follow Us
Novo Integrated Sciences (NVOS)
OTHER OTC:NVOS
Total Valuation
Novo Integrated Sciences has a market cap or net worth of $41.43K. The enterprise value is ―.
Market Cap$41.43K
Enterprise Value―
Share Statistics
Novo Integrated Sciences has 19,730,247 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding19,730,247
Owned by Insiders―
Owned by Institutions0.07%
Financial Efficiency
Novo Integrated Sciences’s return on equity (ROE) is -1.08 and return on invested capital (ROIC) is -40.13%.
Return on Equity (ROE)-1.08
Return on Assets (ROA)-0.50
Return on Invested Capital (ROIC)-40.13%
Return on Capital Employed (ROCE)-0.47
Revenue Per Employee115.60K
Profits Per Employee-115.39K
Employee Count115
Asset Turnover0.41
Inventory Turnover7.55
Valuation Ratios
The current PE Ratio of Novo Integrated Sciences is ―. Novo Integrated Sciences’s PEG ratio is 0.01.
PE Ratio―
PS Ratio0.43
PB Ratio0.38
Price to Fair Value0.38
Price to FCF-2.48
Price to Operating Cash Flow-0.08
PEG Ratio0.01
Income Statement
In the last 12 months, Novo Integrated Sciences had revenue of 13.29M and earned -16.13M in profits. Earnings per share was -0.90.
Revenue13.29M
Gross Profit5.74M
Operating Income-8.31M
Pretax Income-16.13M
Net Income-16.13M
EBITDA-10.08M
Earnings Per Share (EPS)-0.90
Cash Flow
In the last 12 months, operating cash flow was -5.07M and capital expenditures -5.04K, giving a free cash flow of -5.07M billion.
Operating Cash Flow-5.07M
Free Cash Flow-5.07M
Free Cash Flow per Share-0.26
Dividends & Yields
Novo Integrated Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta3.95
52-Week Price Change50.00%
50-Day Moving Average0.06
200-Day Moving Average―
Relative Strength Index (RSI)52.38
Average Volume (3m)46.26K
Important Dates
Novo Integrated Sciences upcoming earnings date is Dec 10, 2025, After Close (Confirmed).
Last Earnings DateJul 10, 2025
Next Earnings DateDec 10, 2025
Ex-Dividend Date―
Financial Position
Novo Integrated Sciences as a current ratio of 0.37, with Debt / Equity ratio of 31.63%
Current Ratio0.37
Quick Ratio0.30
Debt to Market Cap0.83
Net Debt to EBITDA-0.38
Interest Coverage Ratio12.74
Taxes
In the past 12 months, Novo Integrated Sciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Novo Integrated Sciences EV to EBITDA ratio is -0.95, with an EV/FCF ratio of -4.16.
EV to Sales0.72
EV to EBITDA-0.95
EV to Free Cash Flow-4.16
EV to Operating Cash Flow-4.25
Balance Sheet
Novo Integrated Sciences has $844.58K in cash and marketable securities with $4.71M in debt, giving a net cash position of -$3.87M billion.
Cash & Marketable Securities$844.58K
Total Debt$4.71M
Net Cash-$3.87M
Net Cash Per Share-$0.20
Tangible Book Value Per Share-$0.29
Margins
Gross margin is 39.70%, with operating margin of -62.54%, and net profit margin of -121.32%.
Gross Margin39.70%
Operating Margin-62.54%
Pretax Margin-121.32%
Net Profit Margin-121.32%
EBITDA Margin-75.79%
EBIT Margin-126.23%
Analyst Forecast
The average price target for Novo Integrated Sciences is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price Target―
Price Target Upside―
Analyst ConsensusModerate Sell
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―